Development & Aid, Environment, Headlines, Health, North America

ENVIRONMENT: Studies Show why DDT Still Widely Used to Fight Malaria

Stephen Leahy

BROOKLIN, Canada, Aug 15 2002 (IPS) - New genetic tests suggest that it may be more difficult than believed to develop an effective vaccine to fight malaria, leaving the controversial pesticide DDT as the most effective killer of the parasite that causes the disease.

Plasmodium falciparum, the bug responsible for most malarial fatalities, has become resistant to many drugs because of its genetic complexity, according to scientists at the U.S. National Institutes of Health (NIH).

Their findings were reported in the journal Science.

Those results likely mean continued reliance on the controversial pesticide DDT, in spite of a United Nations Environment Program (UNEP) treaty to eliminate or curtail use of the pesticide and other persistent organic pollutants.

Malaria kills up to 2.7million people and infects more than 200 million individuals each year. The parasitic disease is present in 90 countries and widespread in Africa, India, Brazil, Sri Lanka, Vietnam, Colombia and the Solomon Islands.

Ninety per cent of all malaria cases are in sub-Saharan Africa. While mosquitoes get all the blame for the disease, they simply act like taxis, transporting disease-carrying parasites from one warm-blooded animal to another.

It turns out that the most infamous – P. falciparum – is not only deadly; it has been around a long, long time.

Age is important because newer organisms have had less time to evolve genetic complexity, which is an important factor that researchers consider when they develop vaccines or control agents.

In the late 1990s, scientists studied 10 genes of the malaria parasite and concluded that P. falciparum was relatively young – 3,000 to 5,000 years old – and genetically similar from place to place. Those qualities should have made it easy to control.

But NIH researchers conducted a new, and much more in-depth, investigation into the genome of the malaria parasite and uncovered something quite different – P. falciparum is genetically more diverse and much older, from 100,000 to 180,000 years old.

“We speculate, that when the human population grew, the malaria parasite grew with it,” said Xin-zhuan Su of the National Institute of Allergy and Infectious Diseases.

In a second study, Su and colleagues used this genomic information to learn more about how some P. falciparum became resistant to the powerful anti-malaria drug, chloroquine.

Using DNA fingerprinting from 87 parasites taken from patients worldwide, they learned that the African parasite that developed resistance in the late 1970s did not arise independently but came from Southeast Asia. It took only 10 to 15 years for these resistant parasites to spread throughout Africa said Su.

“This means that when a drug or vaccine-resistant parasite arises, it will not take long for this resistance to spread to other continents, reflecting human travel – particularly by air – and the high transmission rate via mosquitoes in Africa,” added Su.

The findings imply that resistance to chloroquine and other anti-malaria drugs can arise and spread more pervasively than previously thought, and argues for careful monitoring of drug programmes.

Those findings may also make it more difficult to rid the world of DDT, a long-lasting, endocrine-disrupting pesticide linked to cancer and low birth weights. Widespread DDT use in agriculture has proven to be highly toxic to wildlife and persists in the environment for decades.

The United States banned its use for most purposes in 1973.

The Convention on Persistent Organic Pollutants (POPs) was signed in Stockholm, Sweden last year with the goal of phasing out or severely restricting the production and use of 12 chemicals, such as PCBs, DDT and dioxins.

The substances are known or suspected to wreak havoc in human and animal tissue, damaging the nervous and immune systems and causing reproductive, developmental disorders, as well as cancer.

Earlier this month, the World Health Organization (WHO) released a ‘State-of-the-Science’ report confirming that hormone-disrupting chemicals like DDT are responsible for “adverse trends in human health”.

While 151 countries signed the POPs treaty, only nine have ratified the convention, which goes into force only after ratification by 50 countries.

Treaty advocates like the World Wildlife Fund (WWF) and other non-government organisations (NGOs) are urging governments to ratify prior to the World Summit on Sustainable Development in Johannesburg, South Africa from Aug. 26 to Sep. 4.

Because DDT remains effective in controlling the disease in some parts of the world, the POPs treaty does not ban it. The intent is to restrict its use to spraying inside homes rather than employing it in aerial bombardments of thousands of acres of mosquito territory.

In spite of the treaty, DDT use may be increasing due to the malaria parasite’s growing resistance to less toxic pesticides, such as pyrethroids, and because of an upswing in malarial outbreaks.

Despite concerns, the WHO remains a strong supporter of controlled DDT use.. As partner in the Roll Back Malaria global programme, the organisation supports a diverse approach to malarial control.

The tools endorsed by the programme include: pesticide-impregnated bed-nets (which reduce the need for indoor spraying); odour-baited cloth targets to attract and destroy disease-carrying insects; lower-risk pesticides, used in rotation to avoid the development of resistance; widespread elimination of mosquito breeding grounds and introducing natural predators and sterile insects.

 
Republish | | Print |

Related Tags